Investing in the healthcare sector is a stable choice regardless of market conditions. Companies that offer dividends consistently are financially secure. Three healthcare mutual funds to consider are Franklin Biotechnology Discovery Fund (FBDIX), Fidelity Select Biotechnology Portfolio (FBIOX), and Fidelity Advisor Biotechnology Fund (FBTIX), all with a Zacks Mutual Fund Rank #1.

Each fund has specific focuses and investment strategies. Franklin Strategic Biotechnology Discovery Fund (FBDIX) seeks capital appreciation by investing in biotechnology companies worldwide. FBDIX has a three-year annualized return of 23.3% and an expense ratio of 1.01%.

Fidelity Select Biotechnology Portfolio (FBIOX) aims for capital appreciation by investing in biotechnological companies. FBIOX has a three-year annualized return of 17.2% and holds 162 issues, with 16.7% of assets in AbbVie Inc. as of August 2025.

Fidelity Advisor Biotechnology Fund (FBTIX) focuses on biotech-related stocks globally, using fundamental analysis for investment decisions. FBTIX boasts a three-year annualized return of 17.9% and has been managed by Eirene Kontopoulos since July 2018.

Quantum Computing is the next big technological leap, with companies like Microsoft, Google, and Amazon investing in its development. Stock Strategist Kevin Cook identifies 7 stocks set to dominate this sector. Investors can position their portfolios for this opportunity now.

For more information on healthcare mutual funds and Quantum Computing stocks, visit Zacks Investment Research for detailed reports and analysis.

Read more at Nasdaq: 3 Healthcare Mutual Funds Worth Betting On